Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition.
Roca-Portoles A, Rodriguez-Blanco G, Sumpton D, Cloix C, Mullin M, Mackay GM, O'Neill K, Lemgruber L, Luo X, Tait SWG.
Roca-Portoles A, et al. Among authors: luo x.
Cell Death Dis. 2020 Aug 13;11(8):616. doi: 10.1038/s41419-020-02867-2.
Cell Death Dis. 2020.
PMID: 32792521
Free PMC article.